Pregnancy and Neonatal Outcomes Following Antenatal Exposure to Raltegravir: a Pooled Analysis From the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)
Clinical trial NCT05751031 · UNKNOWN
Trial details
- NCT number
- NCT05751031
- Sponsor
- Fondazione Penta UK
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-02-20
- Primary completion
- 2024-02-20
- Enrollment
- 1200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.